Lobbying client · LD-2 disclosures
Amryt Pharma
Massachusetts
11 filings from 2 registrants · 2022–2023 · latest filed Feb 28, 2024
Reported on its behalf
$430K
every LD-2 on file
Its own filed spend
$150K
lobbying for itself
Fees to outside firms
$280K
across every firm on file
Spend over time
Every filing period on record, as reported. One column per filed period — a period with no column is a period with no filing, not a zero.
Basis · Amendments and terminations supersede the original report for the same registrant, client and period, so a revised quarter is counted once at its latest filed value. Registration-only filings carry no activity money and are excluded from these totals.
Who lobbies for them
Every outside firm that has filed on this client's behalf, by fees reported.
Reported as lobbying expenses
Money reported as spent on lobbying rather than as a fee paid to an outside firm. See the full list.
What they lobby on
Issue areas declared on the filings, ranked by how many filings name each one.
Health Issues
HCR
11 filings
$430K on those filings
Medicare/Medicaid
MMM
3 filings
$120K on those filings
Note · A filing names one to several issue areas and reports a single dollar figure for the period, so the same money appears beside every issue that filing declares. The dollar column is therefore — it is not a split of the total, and these figures sum above it. Filing counts do not double-count.
Bills named in the filings
Every bill reference extracted from the filings' activity descriptions.
Who did the lobbying
Every lobbyist named on this client's filings.
- Amy Jensen Splitoak Strategies LLCCovered position: 1999-2001 Assistant to the Speaker for Policy; 2003-2005 Special Assistant to the President for Legislative Affairs9 filingsthrough 2023
- Sarah Kuehl Egge Splitoak Strategies LLCCovered position: Legislative Assistant to Senator Bob Kerrey; Senior Budget Analyst for Democratic staff of the Senate Budget Committee (Sen. Kent Conrad); Deputy Staff Director, Joint Select Committee on Deficit Reduction9 filingsthrough 2023
- Lisa F Nelson Amryt Pharma5 filingsthrough 2023
- Kristen Elizabeth Shatynski Splitoak Strategies LLC Professional Staff, House E&C Committee to Cathy McMorris Rodgers (2021-22) & Greg Walden (2017-21); Leg. Asst., Rep. Greg Walden, 4/2015-1/2017; Leg. Asst., Rep. Jackie Walorski, 10/2013-4/2015; Leg. Asst., Rep. Devin Nunes, 10/2012-10/2013
The filings
Every filing on record. Each row links to its full disclosure.
This record groups every filed spelling of the client's name into one entity, so "MERCK & CO., INC." and "MERCK & CO INC" read as the same company. The grouping is the client's normalized name — organizations that file under genuinely different names appear separately. Handle: amryt-pharma.